Oxurion NV (GB:0G99) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Oxurion NV, a Belgian biopharmaceutical firm, has announced receiving a transparency notification from Atlas Special Opportunities LLC, which now holds over 20% of Oxurion’s shares. The stake was acquired through the purchase of voting securities, surpassing the legal threshold for disclosure under Belgian law. Oxurion is known for developing advanced therapies for retinal disorders.
For further insights into GB:0G99 stock, check out TipRanks’ Stock Analysis page.
